Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

Clinical trial NCT02581163 · COMPLETED

Trial details

NCT number: NCT02581163
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Hepatitis C, Genotype 1 or 4

Start date: 2015-10-07
Primary completion: 2018-02-12
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.